Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Journal of Oncology Pharmacy is Scopus-indexed (Q4, CiteScore 1.1). Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1783-3914Verify ISSN ↗2032-7072Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 334 / 428 | 22nd | Q4 |
| Pharmacology | 269 / 328 | 18th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present (also 2008–2015), best quartile Q4, CiteScore 1.1.
European Journal of Oncology Pharmacy is Q4 in Oncology (rank 334 of 428) and Q4 in Pharmacology (rank 269 of 328), by CiteScore 2025.
European Journal of Oncology Pharmacy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.1, quartile Q4, 22nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.211, quartile Q4, with an H-index of 7.
European Journal of Oncology Pharmacy is published by Lippincott Williams and Wilkins. Its print ISSN is 1783-3914 and its online ISSN is 2032-7072.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Journal of Oncology Pharmacy has an h-index of 7 and a 2-year mean of 0.89 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q4. On 2-year citations it ranks #302 of 424 Scopus journals in Oncology.
European Journal of Oncology Pharmacy published 1 papers in 2025; its busiest recent year was 2018 with 19. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 27 research articles (2021–2026), authors are most often from France (28.4%), Netherlands (15.4%) and United States (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.